"Our cancer patients are able to have all of their needs met at Sanford Cancer Center in Bismarck because we are the only health care provider in the region with a comprehensive cancer program, ranging from surgery and radiation to chemotherapy and rehabilitation."

During the past decade, Medcenter One Hospital Cancer Care Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 72 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medcenter One Hospital Cancer Care Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 77 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Eastern Cooperative Oncology Group" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medcenter One Hospital Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 110 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Medcenter One Hospital Cancer Care Center" are "Breast Cancer" (29 trials), "Lung Cancer" (20 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (15 trials), "Lymphoma" (8 trials) and "Melanoma (Skin)" (7 trials). Many other conditions were trialed in "Medcenter One Hospital Cancer Care Center" in a lesser frequency.

Most popular intervention types in "Medcenter One Hospital Cancer Care Center" are "Drug" (89 trials), "Other" (38 trials), "Biological" (34 trials), "Radiation" (20 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (28 trials), "carboplatin" (16 trials), "radiation therapy" (15 trials), "bevacizumab" (11 trials) and "paclitaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Medcenter One Hospital Cancer Care Center" are 89 trials for "All" genders, 17 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Medcenter One Hospital Cancer Care Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 96 completed trials in Medcenter One Hospital Cancer Care Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Medcenter One Hospital Cancer Care Center, 7 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".